F.D.A. Plans to Authorize Pfizer Boosters for All Adults This Weeknews2021-11-17T01:17:59+00:00November 17th, 2021|The New York Times|
What Happens Next as F.D.A., C.D.C. Weigh Covid Shots for Childrennews2021-10-26T12:40:51+00:00October 26th, 2021|The New York Times|
F.D.A. Says Pfizer Vaccine’s Benefits Outweigh Key Risks in Children 5 to 11news2021-10-23T03:18:50+00:00October 23rd, 2021|The New York Times|
Pfizer Says Booster Shots of Its Vaccine Are Highly Protective Against Covidnews2021-10-22T00:45:33+00:00October 22nd, 2021|The New York Times|
F.D.A. Authorizes Moderna and Johnson & Johnson Booster Shotsnews2021-10-21T01:49:57+00:00October 21st, 2021|The New York Times|
Where Things Stand on Boosters for Three Vaccines in the U.S.news2021-10-14T19:36:30+00:00October 14th, 2021|The New York Times|
Pfizer Vaccine Protection Wanes, C.D.C. Study Showsnews2021-09-17T21:47:00+00:00September 17th, 2021|The New York Times|
F.D.A. Aims to Give Final Approval to Pfizer Vaccine by Early Next Monthnews2021-08-04T08:25:24+00:00August 4th, 2021|The New York Times|
U.S. Officials Press Pfizer for More Evidence of Need for Booster Shotnews2021-07-13T03:14:09+00:00July 13th, 2021|The New York Times|
Citing the Delta Variant, Pfizer Will Pursue Booster Shots and a New Vaccinenews2021-07-09T01:51:11+00:00July 9th, 2021|The New York Times|
